Insulin resistance, telaprevir, and virological response in hepatitis C: the debate must go on

Hepatology. 2013 Dec;58(6):1874-6. doi: 10.1002/hep.26642. Epub 2013 Oct 24.

Authors

Manuel Romero-Gómez¹, José A Del Campo

Affiliation

¹ UCM Digestive Diseases and CIBERehd, Valme University Hospital, University of Seville, Sevilla, Spain.

PMID: 23913755
DOI: 10.1002/hep.26642

No abstract available

Publication types

Editorial
Comment

MeSH terms

Female
Hepatitis C, Chronic / drug therapy*
Humans
Insulin Resistance / physiology*
Male
Oligopeptides / therapeutic use*

Substances

Oligopeptides
telaprevir